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Abstract

formation. Several differences between advocates and legislators
were modified by participant age.

Conclusion
Our study provides insights for development of knowledge translation strategies to enhance evidence-based policy making for cancer control that are tailored to state-level legislators and advocates.
Additional research efforts should evaluate the effectiveness of
such knowledge translation strategies, particularly among advocates.

Introduction

Introduction
Evidence-based policy plays an important role in prevention of
cancer and other chronic diseases. The needs of actors involved in
policy decision-making should inform knowledge translation
strategies. This study examines the differences between state legislators and advocates in how they seek and use information and
what their preferences are for how research information is framed.

Methods
We conducted a cross-sectional comparison of survey responses
by US advocates (n = 77) and state legislators (n = 265) working
on issues related to cancer control.

Results
Advocates differed significantly from legislators on all demographic characteristics. Advocates reported seeking and using information more frequently than legislators, though legislators used
legislative research bureaus more often (0.45 point difference, P =
.004). Both legislators and advocates prioritized the presentation
and timeliness of research information similarly but reported different preferences for source (information bias, information relevance, delivery of information by trusted person) of research in-

Enactment of evidence-based legislation can produce considerable population effects on preventable conditions such as cancer
and its associated risk factors (1,2). Nonetheless, public health
policy making often is not informed by available evidence (3,4).
Kingdon’s Multiple Streams Framework of how policy change
happens defines the policy stream as the space where solutions
compete for acceptance during decision making around an agreedupon problem (5), such as cancer control. As researchers seek to
translate cancer control knowledge into policy solutions within
this stream, they must consider the needs of actors involved in
policy decision making around control of cancer and its risk
factors and frame their messages accordingly (6,7).
Policy makers value and seek scientific research information (8,9),
and they cite needs of constituents; collaboration and relationships; clarity, relevance, and reliability of research findings; and
timeliness and opportunity as key factors in using research in
policy making (9). Though people from the same institutions often share some preferences for research framing, differences exist
among people involved in policy making (eg, legislators, legislative staff, agency officials) and should be explored (8,10).
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Policy advocates are less often the focus of dissemination research though they play an important role in the policy making
process. Advocacy entails the use of information, resources, and
skills to create changes in the public’s opinion and views of decision makers, which then influence public policies or the policy
process (11,12). Advocates are often channels of communication
to policy makers and routinely build long-term relationships with
them (13). Given their role in evidence-based policy making (14),
it is important to examine how researchers should tailor messages
to policy advocates.
This study considers differences in how legislators and advocates
involved in policy work concerning cancer and its risk factors seek
and use information during policy decision making and what their
preferences are for how research information is framed.

Methods
Design and participants
We conducted a cross-sectional comparison of US advocates and
state legislators who work on issues related to cancer or cancer-related risk factors. Seventy-seven advocates and 265 legislators
participated in the study. We identified the initial sample of advocates by conducting a Google search of the following key words:
advocacy, policy, obesity, physical activity, cancer, or nutrition
and combined these key words with the state name (eg,
California). We used the policyexperts.org and heritage.org Webbased advocacy resources to identify more politically conservative advocacy groups to achieve adequate variability in the sample
by political stance. In each advocacy agency, we defined the contact person as the individual who was responsible for public policy
efforts or worked with government agencies. We verified the accuracy of contact information in the initial contact list (290 contacts) and made corrections where possible, resulting in a final list
of 213 contacts. From February through April 2013, people on the
contact list were repeatedly contacted; telephone numbers for
people we were unable to reach were returned to the queue and
routinely redialed until the end of the data collection period, and
trained personnel conducted telephone interviews with advocates
who agreed to participate. Additional information regarding recruitment procedures is available elsewhere (15).
To obtain the legislator sample, we partnered with the National
Conference of State Legislatures to compile a complete list of all
7,525 state legislators from 50 states and 3 US territories. A random sample of 2,000 legislators was selected from this population,
and each legislator was contacted up to 10 times for participation
in the study. Those who agreed to participate completed inter-

views by telephone from January through October 2012. Of those
legislators contacted, 862 completed the survey, and 161 started
but did not complete it; 857 legislators declined to participate.
To ensure comparability with the advocate sample, we retained for
analysis the legislators who indicated that cancer or cancer risk
factors (tobacco use, diet/nutrition, physical activity, obesity) were
among their legislative priorities. We also focused on this group of
legislators, because they were more likely to already work on
policies related to cancer control or serve on related legislative
committees. We based this selection on responses to 2 survey
questions: 1) an open-ended question asking, “What issues are
your legislative priorities?” and 2) a question asking participants
to choose their most important health issues from a 19-item list
where the last item (“other”) was also open-ended. If the legislator selected cancer, diet/nutrition, physical activity, obesity, or tobacco use/cessation in the second question, they were included in
the study. The open-ended responses were also screened for the
terms cancer, diet, nutr, activ, exercise, obes, smok, and tobacco,
and 2 independent coders reviewed these participant responses, resolved contrasting coding decisions through discussion, and coded
the responses as prioritizing cancer or cancer risk factors or not
prioritizing cancer or cancer risk factors. The 265 legislators selected through this process were included in the study. The institutional review board of Washington University in St. Louis approved this study.

Measures
The main outcomes in our study were information seeking and use
and preferences for how research information is framed. We adapted questions from a previously developed measure validated with
state legislators and cognitively tested with representatives of the
advocate sample (8,15–17). To measure information seeking and
use, we asked participants to rank a series of statements on a 5point scale (1 = never, 5 = always) on the basis of how often they
used each source of information when working on policy issues.
To measure preferences for how research information is framed,
we asked participants to rank a series of statements on a 5-point
scale (1 = low, 5 = high) indicating how important it was to the
participant that research information have a given characteristic.
The research information characteristics represented 3 research information domains: source, presentation, and timeliness (18).
In addition, we collected characteristics of participants: sex, age
(<40 y, 40–49 y, 50–59 y, or ≥60 y), educational attainment (some
college, trade, technical, or vocational education or less; college
degree; or postgraduate degree), self-rated health status (excellent,
very good, good, or fair or poor), and the number of years the participant had spent in the legislature or in advocacy. We also measured political stance by asking participants to rate themselves on
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social and fiscal issues and collapsing their answers into 3 categories: liberal (slightly liberal, liberal, extremely liberal), moderate,
and conservative (slightly conservative, conservative, extremely
conservative).

older advocates more often talked with colleagues about research
on issues important to them and took results of a scientific study
into account than older legislators, whereas there was no difference for younger advocates and legislators.

Data analysis

For the items related to preferences for research information framing, there were significant differences (3 out of 4 items) between
the 2 groups’ preferences for the source of research information.
Advocates put a higher priority than did legislators on research information that was unbiased and relevant to their organization and
constituents overall. Younger legislators put a higher priority on
information that was delivered to them by someone they know or
respect (4.40 ranking on the 5-point scale) than did younger advocates (3.58), whereas both older advocates (4.17) and older legislators (4.19) found this to be important. Advocates and legislators put a similar priority on research information that supports the
position they hold. Legislators’ and advocates’ preferences were
similar for the presentation (research information being understandably written, presented briefly and concisely, containing costeffectiveness data, telling a story of relevance to constituents, and
providing policy options) and most timeliness issues (research information is available at the time of decision-making and containing implications that are politically feasible). Whereas younger legislators prioritized research information dealing with high-priority issues higher than younger advocates, we found no difference
between older legislators and older advocates.

2

We used Pearson’s χ to examine differences in group characteristics for categorical variables and Wilcoxon rank sum test for continuous variables. To examine the differences between legislators
and advocates in information-seeking, information use, and preferences for framing of research information, we used a one-way analysis of variance. In addition, we examined whether age modified
the differences between advocates and legislators by using the interaction term between type of actor (legislator, advocate) and age
(<50 y, ≥50 y), and where significant, the analyses were stratified
by age. We used SAS version 9.4 (SAS Institute, Inc) to conduct
analyses.

Results
The response rates for the legislator survey was 54%, and the response rate for the advocate survey was 36%. Advocates differed
significantly from legislators on all characteristics (Table 1). More
advocates were female (61.0%), whereas most legislators were
male (61.7%). Advocates were younger than legislators and had
higher educational attainment. Legislators rated their health status
lower than advocates did and had more conservative views on social and fiscal issues.
We examined differences between advocates and legislators in
their information seeking, information use, and preferences for
framing of research information (Table 2). Advocates reported
seeking and using information more frequently than did legislators, except for the “Ask research bureaus (external legislative research organizations) for information on the issue” statement,
which the legislators rated more highly. The groups differed on
most items pertaining to information-seeking (explore what other
states are doing, read scientific reports, read or watch popular media stories, ask research bureaus for information) overall, though
they did not differ significantly on the statement “Contact scientific researchers or experts for advice.” We conducted the same analyses by age group solely for outcomes for which the interaction
terms between participant group and age were significant (Table
3). Older advocates (≥50 y) more often attended seminars and
presentations than older legislators (P < .001), but we found no
significant difference for younger (<50y) participants (Table 3).
For practices related to information use, advocates used research
to justify decisions more often than did legislators overall, and

Discussion
We examined differences in how state-level legislators and advocates working in cancer control use research information, specifically comparing information-seeking, information use, and preferences for framing of research information, and found that advocates overall used and sought information more often than legislators did, but legislators more often used legislative research organizations for information. Though both groups gave high rankings
to information that is well presented and timely, we found differences in how the 2 groups prioritized the source of information.
Legislators emphasized relationships, whereas advocates rated objectivity and relevance to constituents more highly. Several of the
differences between advocates and legislators were associated
with age.
Studies such as ours are important for developing and tailoring
knowledge translation strategies for policy makers and advocates.
Such studies also begin to fill a gap in research regarding knowledge translation among advocacy organizations. Our findings
show that both groups valued research evidence and used research
reports and studies in policy making, though advocates more often than legislators, but both groups infrequently contacted re-
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searchers or experts for advice. Both groups preferred research information that is understandable, concise, relevant, actionable,
timely, and includes cost-effectiveness data. Younger advocates,
who make up most of the advocates group, did not prioritize framing of information by someone they know or trust, so integration
of this item into translation strategies tailored to advocates may be
of less importance. However, for legislators, who prioritize this
way of receiving research information, knowledge translation
strategies should include the establishment of a relationship of
trust with the legislator by the researcher or by another actor who
is able to serve as an intermediary. Findings of previous studies indicate that these relationships represent a long-term investment,
requiring considerable time, effort, and in-person communication
(13,19,20). In addition, because legislators reported often using internal legislative research bureaus to obtain information, researchers and advocates should develop strategies for more effective
evidence sharing with these entities. Advocates placed a higher
priority on information that was unbiased and relevant to their
constituents than did legislators; therefore, ensuring that the research evidence is generalizable to these constituencies and including local data and success stories in dissemination materials
are important.
This study’s findings are largely in line with existing literature on
knowledge translation among legislators and other policy makers.
A qualitative study of Wisconsin and New York state legislators
found that they value research evidence and find evidence useful
when it is credible, accessible to them, and available when decisions are made (16). The study found that legislators would like
to receive information in a format that provides opportunity for interaction, including seminars, interactions with experts, and discussion with colleagues (16). A large amount of research exists on
barriers and facilitators to the use of evidence, though little has
been conducted with advocates (19). The top 5 barriers and facilitators to the use of evidence by policy makers are availability and
access to research; clarity, relevance, and reliability of research
findings; collaboration and relationships between policy makers
and researchers; and policy maker research skills (19). A qualitative study with nutrition and obesity researchers active in policy
dissemination found that cultivating relationships with policymakers, use of intermediaries (eg, professional associations or
nonprofit organizations that aim to improve knowledge sharing
between producers and users of knowledge) in this work, and
providing relevant policy communication training to researchers
are promising strategies for success in knowledge translation into
policy (20). Moreland-Russell et al qualitatively examined how legislative testimony influences the actions of legislators in our
study and found that it influences awareness of issues and legislative decision-making and that presenter credibility, knowledge, and
expertise increase the influence of testimonies (17).

Eyler et al qualitatively examined how the advocates in our sample
communicate with policy makers, what barriers they experience,
and what strategies they find useful (13) and found that advocates’
perceptions of what works in communicating research to policy
makers matches the preferences reported by state legislators in our
study. Advocates found that developing and maintaining professional relationships with policy makers is essential and takes longterm commitment, and that policy makers like to receive credible,
relevant, and timely information that is understandable and concise and includes cost information (13). Other research, dealing
with obesity prevention policy, showed that advocates are more
aware of and able to communicate policy-relevant evidence (21)
though few studies outside of our project (15) have examined how
advocates prefer to receive research information.
Knowledge translation strategies tailored to advocacy organizations are particularly important, because advocates often act as information channels to policy makers and can support evidencebased policy making through activities not usually carried out by
researchers (12,13,22,23). Advocates routinely build coalitions
around common policy issues and coordinate collective messaging and exchange of information among actors (12) to ensure
that policy makers hear the same coherent meta-message around a
problem. They are also skilled at selecting the appropriate messengers to convey information to policy makers (13). Though researchers can and do participate in the policy making process, they
encounter several barriers to doing so (23,24), and partnerships
with advocacy organizations may address some of these barriers.
The findings from our study may not be equally generalizable to
all states or policy areas. Policy networks (ie, patterns of interaction between public and private actors in policy making) may differ between states, and these networks inform the degree to which
policy activities are coordinated, to what extent new actors or new
ideas are allowed to enter into the policy decision-making sphere,
and what kind of information-framing is necessary (25,26). For
example, in policy networks where legislators or their staff are engaged with other actors through regular contact (27), dissemination strategies may include working through these relationships instead of establishing new ones. In networks that insulate policy decision making from issue interest groups and are thus more resistant to policy change (25), researchers must take these network
structures into account and tailor their dissemination strategies accordingly.
Differences exist between policy topic areas in how acceptable
they are perceived to be by policy makers (28) or how likely they
are to be enacted (29), and different policy issues are associated
with different policymaker research-framing preferences (18). In
addition, high profile policy issues accompanied by high interest
from media and the public may lead to more contested relation-
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ships between policy actors (25), changing the context in which
research translation takes place. Finally, enactment of evidencebased policy is more likely in the presence of an existing policy on
the topic (29), which varies by policy and state. These differences
contribute to the complexity of translating research into policy and
should be taken into account when developing translation
strategies.
This study addresses a gap in the literature on translation of cancer control research into policy and used robust measures of information seeking and information use and preferences for research-framing. However, some limitations must be noted. Different sampling procedures were used to select legislators and advocates, which may have reduced comparability of the 2 groups. We
used a comprehensive sampling frame to recruit legislators,
whereas we did not sample advocates based on a comprehensive
list. In addition, we sampled advocates working on cancer and
cancer risk factor issues from the outset, whereas we selected legislators who were prioritizing these issues in their work on the
basis of their questionnaire responses. In addition, our study’s response rates (54% for legislators, 36% for advocates) may reduce
the generalizability of our findings, although our response rate for
legislators was higher than that achieved in other policy-related
studies (10,30). It is also possible that in both groups a social desirability bias led to higher ratings on questionnaire items related
to research evidence, because the survey was part of an academic
research project. Finally, our study would have been strengthened
by collection of additional qualitative data to examine how and
where participants accessed research, or to assess informationseeking and use beyond participant self-report to validate our
measures.
Our study provides insights for development of knowledge translation strategies to enhance evidence-based policymaking for cancer control that are tailored to state-level legislators and advocates.
When working with both groups, research information should be
understandable, concise, relevant, actionable, and timely, and
should include cost-effectiveness data. Translation strategies for
legislators should include partnering with individuals and groups
that have existing personal relationships with legislators and their
staff and more effective evidence-sharing with legislative research
bureaus. For advocates, ensuring that the research evidence is generalizable to their constituencies and including local data and success stories in dissemination materials are important. In addition,
though a growing knowledge base exists on how to disseminate
research to policy makers, few studies identify strategies for
knowledge translation to advocates. Future research efforts should
examine how these key actors in the policymaking process can be
more effectively engaged to promote evidence-based policy making.
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Tables
Table 1. Characteristics of Participating Advocates (N = 77) and Legislators (N = 265) Involved in Cancer Control, Study of Information Use, Information-Seeking,
and Research Framing Preferences, United States, 2012–2013a
Characteristic

Advocates

Female

Legislators

P Valueb

47 (61.0)

75 (28.3)

<.001

<40

21 (27.6)

11 (5.5)

<.001

40–49

20 (26.3)

29 (14.4)

50–59

15 (19.7)

51 (25.4)

≥60

20 (26.3)

110 (54.7)

Age, y

Education
Some college, trade, technical, or vocational education or less

1 (1.3)

46 (17.4)

College degree

28 (36.8)

105 (39.6)

Postgraduate degree

47 (61.8)

114 (43.0)

Excellent

33 (43.4)

61 (23.0)

Very good

29 (38.2)

97 (36.6)

Good

12 (15.8)

85 (32.1)

2 (2.6)

22 (8.3)

Liberal

43 (65.2)

77 (29.3)

Moderate

10 (15.2)

49 (18.6)

Conservative

13 (19.7)

137 (52.1)

Liberal

35 (49.3)

27 (10.2)

Moderate

15 (21.1)

58 (22.0)

Conservative

21 (29.6)

179 (67.8)

14.41 (9.88)

9.11 (7.67)

<.001

Self-rated health

Fair or poor

.001

Political stance, social issues
<.001

Political stance, fiscal issues

Number of years in legislature or advocacy, mean (standard deviation)
a
b

<.001

<.001

Values expressed as no. (%) unless otherwise indicated.
Differences were examined using Pearson’s χ2 for categorical variables and Wilcoxon rank sum test for the continuous variable.
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Table 2. Comparison of Participating Advocates (N = 77) and Legislators (N = 265) Involved in Cancer Control, Study of Information Use, Information-Seeking, and
Research Framing Preferences, United States, 2012–2013
Advocates
Variable

Legislators

Mean Score (Standard Deviation)

Mean Difference
Between Scores of
Legislators and
Advocates

P Valuec

Seeking and Using Informationa
Using information
Use research to justify a decision you made

4.63 (0.10)

4.16 (0.05)

−0.48

<.001

Talk with your colleagues about research on issues important to you

4.37 (0.11)

4.22 (0.06)

−0.15

.20

Take the results of a relevant scientific study into account (when
making a decision)

4.29 (0.10)

4.00 (0.05)

−0.28

.01

Explore what other states are doing on the issue

4.12 (0.11)

3.71 (0.06)

−0.41

.001

Read scientific research reports on the issue

3.96 (0.13)

3.38 (0.07)

−0.58

<.001

Read or watch popular media stories on the issue

3.82 (0.13)

2.95 (0.07)

−0.87

<.001

Attend seminars or presentations where research is discussed

3.38 (0.13)

2.91 (0.07)

−0.47

.002

Contact scientific researchers or experts for advice

3.16 (0.14)

2.91 (0.08)

−0.25

.12

Ask research bureaus (external legislative research organization) for
information on the issue

2.89 (0.13)

3.34 (0.07)

0.45

.004

Seeking information

Preferences for Framing of Research Informationb
Source
Research information is unbiased

4.62 (0.10)

4.36 (0.06)

−0.26

.03

Research information is relevant to my constituents/to my
organization and those my organization serves

4.62 (0.08)

4.34 (0.05)

−0.28

.004

Research information is delivered to me by someone I know or respect

3.87 (0.10)

4.20 (0.05)

−0.33

.004

Research information supports a position I hold

3.61 (0.13)

3.58 (0.07)

−0.02

.88

Research information is understandably written

4.47 (0.08)

4.50 (0.05)

0.04

.71

Research information is presented in a brief, concise way

4.41 (0.09)

4.42 (0.05)

0.01

.90

Research information provides data on the cost-effectiveness of a
policy

4.39 (0.09)

4.30 (0.05)

−0.09

.42

Research information tells a story of how a health issue affects my
constituents / my organization and those my organization serves

4.32 (0.10)

4.15 (0.05)

−0.17

.12

Research information provides policy options

4.17 (0.10)

4.15 (0.05)

−0.03

.81

Research information is available at the time decisions are being
made

4.41 (0.09)

4.43 (0.05)

0.03

.81

Research information deals with an issue that I think is a high priority
for state legislative policy action

4.28 (0.09)

4.36 (0.05)

0.09

.40

Research implications are politically feasible at the time I receive
them

3.49 (0.13)

3.43 (0.07)

−0.07

.66

Presentation

Timeliness

a

Based on participants’ rating of statements by how often they performed the action (1 = never, 5 = always). Within each subheading, the statements are sorted
by the score in the advocates group.
b
Based on participants’ ratings of the statements by how much they prioritize the characteristic of the information (1 = low, 5 = high). Within each subheading, the
statements are sorted by the score in the advocates group.
c
Differences in means were examined by using analysis of variance.

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
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Table 3. Comparison of Participating Advocates (N = 76) and Legislators (N = 201) Involved in Cancer Control, by Age, Study of Information Use, InformationSeeking, and Research Framing Preferences, United States, 2012–2013a
Aged <50 Years

Variable

Advocates(n =
41), Mean
Score (SD)

Legislators(n =
40), Mean Score
(SD)

Aged ≥50 Years

P Value

Advocates(n =
35), Mean
Score (SD)

b

Legislators(n =
161), Mean
Score (SD)

P Valueb

Seeking and Using Informationc
Using information
Talk with your colleagues about research on
issues important to you

4.20 (0.14)

4.40 (0.14)

.30

4.56 (0.16)

4.19 (0.07)

.04

Take the results of a relevant scientific study
into account (when making a decision)

4.05 (0.16)

4.10 (0.16)

.82

4.54 (0.13)

3.98 (0.06)

<.001

2.98 (0.19)

2.93 (0.19)

.85

3.80 (0.18)

2.91 (0.09)

<.001

Seeking information
Attend seminars or presentations where
research is discussed

Preferences for Framing of Research Informationd
Source
Research information is delivered to me by
someone I know or respect

3.58 (0.14)

4.40 (0.14)

<.001

4.17 (0.14)

4.19 (0.07)

.88

4.02 (0.11)

4.48 (0.11)

.006

4.56 (0.13)

4.37 (0.06)

.18

Timeliness
Research information deals with an issue that I
think is a high priority for state legislative policy
action
a

This table includes outcomes for which the interaction terms between participant group and age were significant. Within each subheading, the statements are
sorted by score in the advocates group.
b
Differences in means were examined by using analysis of variance.
c
Participants were asked to rate the statements based on how often they perform the action described in the statement (1 = never, 5 = always).
d
Participants were asked to rate the statements based on how much they prioritize the characteristic of the information (1 = low, 5 = high).
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